title: Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016.
authors.affiliation: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Jing
authors.initials: J
authors.lastname: Luo
authors.affiliation: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
authors.affiliation: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Jerry
authors.initials: J
authors.lastname: Avorn
mesh_terms: D014487:Centers for Medicare and Medicaid Services, U.S.; D017281:Cost of Illness; D004837:Epinephrine / Q000008:administration & dosage* / Q000191:economics; D005102:Health Expenditures / Q000706:statistics & numerical data; D006801:Humans; D007273:Injections, Intramuscular / Q000191:economics* / Q000295:instrumentation; D007349:Insurance, Health, Reimbursement / Q000191:economics* / Q000706:statistics & numerical data; D008329:Managed Care Programs / Q000191:economics; D008484:Medicaid / Q000191:economics* / Q000706:statistics & numerical data; D014481:United States
chemical_list: D004837:Epinephrine